Neurologian yksikkö
Department of Neurology

Julkaisut 2000
Publications 2000

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Alafuzoff I et al. Selegiline treatment and the extent of degenerative changes in brain tissue of patients with Alzheimer´s disease.
2 Alafuzoff I et al. Severity of cardiovascular disease, apolipoprotein E genotype, and brain pathology in aging and dementia.
3 Alafuzoff I et al. Lower counts of astroglia and activated microglia in patients with Alzheimer´s disease with regular use of non-steroidal anti-inflammatory drugs.
4 Aura J, Riekkinen P Jr. Pre-training blocks the improving effect of tetrahydroaminoacridine and D-cycloserine on spatial navigation performance in aged rats.
5 Bezvenyuk Z et al. Excision of DNA loop domains as a common step in caspase-dependent and -independent types of neuronal cell death.
6 Bezvenyuk Z et al. Protective effect of suramin against cell death in rat cerebellar granular neurons and mouse neuroblastoma cells.
7 Björklund M et al. Overexpression of alpha2C-adrenoceptors impairs water maze navigation.
8 Campbell BCV et al. Accumulation of insoluble alfa-synuclein in dementia with lewy bodies.
9 Del Sette M et al. Internal borderzone infarction a marker for severe stenosis in patients with symptomatic internal carotid artery disease.
10 Elovaara I, Pirttilä T. Kortikosteroidit multippeliskleroosin ja optikusneuriitin hoidossa.
11 Erkinjuntti T, Hänninen T. Huomio Alzheimerin taudin varhaiseen taudinmääritykseen ja hoitoon.
12 Fratiglioni L et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts.
13 Geroldi C et al. Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer´s disease: a volumetric MRI study.
14 Helisalmi S et al. Is the presenilin-1 E318G missense mutation a risk factor for Alzheimer´s disease?
15 Helisalmi S et al. The leucine (7)-to-proline (7) polymorphism in the signal peptide of neuropeptide y is not associated with Alzheimer´s disease or the link apolipoprotein E.
16 Henderson RD et al. Angiographically defined collateral circulation and risk of stroke in patients with severe carotid artery stenosis.
17 Hiltunen M. A Molecular Genetic Study of Factors Involved in Alzheimer´s Disease.
18 Hiltunen M et al. Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer´s disease family: an Alu core sequence-stimulated recombination?
19 Hänninen T, Soininen H. Mild cognitive impairment as a warning sign of dementia.
20 Inzitari D et al. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis.
21 Inzitari D et al. Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke.
22 Jagger C et al. Prognosis with dementia in Europe: a collaborative study of population-based cohorts.
23 Jolkkonen J et al. MAO-B inhibition by a single dose of l-Deprenyl or Lazabemide does not prevent neuronal damage following focal cerebral ischaemia in rats.
24 Jolkkonen J et al. Behavioral effects of the alpha2-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats.
25 Jolkkonen J et al. Effects of fluoxetine on sensorimotor and spatial learning deficits following focal cerebral ischemia in rats.
26 Kappelle LJ et al. Small, unruptured intracranial aneurysms and management of symptomatic carotid artery stenosis.
27 Karonen JO et al. Combined SPECT and diffusion-weighted MRI as a predictor of infarct growth in acute ischemic stroke.
28 Koivisto AM et al. Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: a population-based longitudinal study.
29 Kuhmonen J et al. The neuroprotective effects of (-)deprenyl in the gerbil hippocampus following transient global ischemia.
30 Kuikka JT, Hartikainen P. Heterogeneity of cerebral blood flow: a fractal approach.
31 Kyrylenko S et al. Expression of transcriptional repressor proteins mSin3A and 3B during Aging and replicative senescence.
32 Laakso MP et al. Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer´s disease: a morphometric MRI study.
33 Laakso MP et al. Diagnosis of Alzheimer`s disease: MRI of the hippocampus vs delayed recall.
34 Laakso MP et al. Hippocampus in Alzheimer´s disease: A 3-year follow-up MRI study.
35 Laakso MP et al. A volumetric MRI study of the hippocampus in type 1 and 2 alcoholism.
36 Lakka H-M et al. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men.
37 Lees KR et al. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial.
38 Lehtovirta M et al. How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer´s disease ? A review of neuroimaging studies.
39 Lehtovirta M et al. A longitudinal quantitative EEG study of Alzheimer´s disease: relation to apolipoprotein E polymorphism.
40 Lobo A et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts.
41 Mikkonen M et al. Morphology of spiny neurons in the human entorhinal cortex: intracellular filling with lucifer yellow.
42 Nissinen J et al. A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat.
43 Nousiainen I et al. Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy.
44 Nousiainen I et al. Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared with healthy volunteers.
45 Nousiainen I et al. Visual function in patients with the GABAergic anticonvulsant drug tiagabine.
46 Nuutinen J et al. Early serial SPET in acute middle cerebral artery infarction.
47 Overmyer M et al. DNA fragmentation, gliosis and histological hallmarks of Alzheimer´s disease.
48 Partanen J et al. Epilepsiapesäkkeen paikannus.
49 Partanen J et al. Vascular dementia and white matter changes: electrophyciological tests.
50 Partanen K et al. Varhaisen dementian kuvantamisdiagnostiikka.
51 Pihlajamäki M et al. Verbal fluency activates the left medial temporal lobe: a functional magnetic resonance imaging study.
52 Pirttilä T. MS-taudin varhainen diagnoosi tärkeä hoitojen kehittyessä.
53 Pirttilä T et al. Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster.
54 Pitkänen A et al. Association between the density of mossy fiber sprouting and seizure frequency in experimental and human temporal lobe epilepsy.
55 Pitkänen K. Stroke Rehabilitation in the Elderly. A Controlled Study of the Effectiveness and Costs of a Multidimensional Intervention.
56 Puoliväli J. An Experimental Study on the Cholinergic Modulation of Cortical Arousal and Cognitive Functions. With Special Emphasis on Apolipoprotein E.
57 Puoliväli J et al. Apolipoprotein e-deficient mice are not more susceptible to the biochemical and memory deficits induced by nucleus basalis lesion.
58 Puoliväli J et al. Impaired recovery of noradrenaline levels in apolipoprotein E-deficient mice after N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine lesion.
59 Rahkonen T et al. Delirium episode as a sign of undetected dementia among community dwelling elderly subjects: a 2 year follow up study.
60 Roschier M et al. A differential display protocol to identifity differentially expressed mRNAs in potassium-deprived cerebellar granule cells.
61 Rothwell PM et al. Interrelation between plaque surface morphology and degree of stenosis on carotid angiograms and risk of ischemic stroke in oatients with symptomatic carotid stenosis.
62 Rothwell PM et al. Low risk of ischemic stroke in patients with reduced internal carotid artery lumen diameter distal to severe symptomatic carotid stenosis . Cerebral protection due to low poststenotic flow?
63 Ruotsalainen S et al. Blockade of muscarinic, rather than nicotinic, receptors impairs attention, but does not interact with serotonin depletion.
64 Saarelainen T et al. Transgenic mice overexpressing truncated trkB neurotophin receptors in neurons show incresed susceptibility to cortical injury after focal cerebral inschemia.
65 Salmenperä T et al. MRI volumetry of the hippocampus, amygdala, entorhinal cortex, and perirhinal cortex after status epilepticus.
66 Salmenperä T et al. Quantitative MRI volumetry of the entorhinal cortex in temporal lobe epilepsy.
67 Savolainen S et al. MR imaging of the hippocampus in normal pressure hydrocephalus: correlations with cortical Alzheimer`s disease confirmed by pathologic analysis.
68 Scheltens P et al. La rilevazione delle alterazioni strutturali cerebrali nella malttia di Alzheimer: tecniche e strumenti.
69 Schmidt D et al. Tiagabine in the treatment of epilepsy - a clinical review with a guide for the prescibing physician.
70 Soininen H. APOE4 relevance to early diagnosis and treatment of Alzhemer´s disease.
71 Soininen H. Early diagnosis of Alzheimer´s disease.
72 Soininen H, Sulkava R. Milloin aivot tulee kuvata.
73 Suomen muistitutkimusyksiköiden asiantuntijatyöryhmä. Muistihäiriö- ja dementiapotilaan toimintakyvyn ja sairauden vaikeusasteen arviointi.
74 Suuronen T et al. Protective effect of L-Deprenyl against apoptosis induced by okadaic acid in cultured neuronal cells.
75 Tapiola T et al. Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer´s disease.
76 Tapiola T et al. Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and concentration in Alzheimer´s disease.
77 Tatlisumak T et al. Aivoverenkierron häiriöiden toiminnallinen kuvantaminen.
78 Tuomainen S, Hänninen T. Kognitiivinen ikääntyminen.

Neurologian yksikkö Department of Neurology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008